Apogee Therapeutics, Inc., a clinical stage biotechnology company, develops novel biologics for the treatment of atopic dermatitis, asthma, eosinophilic esophagitis, chronic obstructive pulmonary disease, and other inflammatory and immunology indications in the United States. The company develops...
6 insider purchases on record · latest filing 2024-12-16.
Insiders have also filed 131 sale transactions at APGE.